A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study
- Resource Type
- Article
- Source
- In
Gynecologic Oncology March 2012 124(3):569-574 - Subject
- Language
- ISSN
- 0090-8258